Matthew Cave, MD
Enriched profileProfessor, Distinguished University Scholar, Vice Chair for Research in the Department of Medicine · University of Louisville
Matthew Cave is Professor, Distinguished University Scholar, Vice Chair for Research in the Department of Medicine at University of Louisville. OpenAlex indexes 128 publications with 5,605 citations (h-index 36); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 14 Oct 2026
Overview
Updated 14 Oct 2026
Matthew Cave, M.D., is Professor, Distinguished University Scholar, Vice Chair for Research in the Department of Medicine at University of Louisville. The public record shows 128 publications with 5,605 citations (h-index 36), centered on Liver Disease Diagnosis and Treatment, Toxic Organic Pollutants Impact, Drug-Induced Hepatotoxicity and Protection. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 12 companies, 13 NIH-funded awards (2010–2026).
- Most recent indexed publication: 2023 · Alcohol, clinical & experimental research
- Top research focus: Liver Disease Diagnosis and Treatment
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 12 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 66.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Use of Bile Acid Binding Resins to Decrease PFAS Levels Via Colesevalem in Veterans Study
Sponsor: University of Rhode Island
- Zinc Supplementation in Alcoholic Cirrhosis
Sponsor: University of Louisville
- Technology-Based Application To Improve The Triple Therapy Adherence Rate In Subjects With Hepatitis C Infection
Sponsor: University of Louisville
Industry payments
Updated 14 Oct 2026
12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202518 payments$42,515openpaymentsdata.cms.gov ↗
- Intercept Pharmaceuticals, Inc.Program year202516 payments$20,584openpaymentsdata.cms.gov ↗
- Madrigal PharmaceuticalsProgram year202533 payments$20,126openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
38.5%Beta blocker16.3%Carvedilol81%Nadolol19%Part D<11 patientsLoop diuretic8.4%Furosemide100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
37%Rifamycin Antibacterial9.7%Xifaxan100%Part D<11 patientsBile Acid8.1%Ursodiol100%Part D<11 patients+ 4 more classes in this area
Anti-infectives
11.5%Nucleoside and nucleotide reverse transcriptase inhibitors7%Tenofovir Disoproxil Fumarate63%Vemlidy38%Part D<11 patientsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor4.4%Entecavir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
13 NIH research awards on record, funded 2010–2026 per NIH RePORTER. The latest:
- Nutrition and Metabolic Health Center (NMHC) COBRE
University of Louisville
FY2026$2,652,150P20GM161999
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The environmental pollutant, polychlorinated biphenyl 126, alters liver function in a rodent model of alcohol-associated liver disease.
Alcohol, clinical & experimental research
Article2023 - Combined exposure to polychlorinated biphenyls and high-fat diet modifies the global epitranscriptomic landscape in mouse liver.
Environmental epigenetics
Article2021
Most-cited works
by citation count (OpenAlex)- 01
- 02Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytesArticle406 citations2007
- 03Nuclear receptors and nonalcoholic fatty liver diseaseArticle279 citations2016
- 04Zinc and Liver DiseaseArticle240 citations2012
- 05The role of zinc deficiency in alcohol-induced intestinal barrier dysfunctionArticle214 citations2010
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
louisville.edu/medicine/departments/medicine/doctors/cave-matthew
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →louisville.edu ↗ - Other
uoflhealth.org/videos/provider-profile-dr-matthew-cave
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uoflhealth.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →louisville.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →louisville.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →louisville.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →louisville.edu ↗
Editorial & leadership roles
journal and society appointments- Fellow
American Association for the Study of Liver Diseases (FAASLD)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →louisville.edu ↗ - Member
American Association for the Study of Liver Diseases (AASLD)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aasld.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →louisville.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →louisville.edu ↗
Secondary affiliations
appointments beyond the home institution- Staff Physician
Robley Rex Veterans Affairs Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →louisville.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →louisville.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →louisville.edu ↗
- Deputy Director
UofL Center for Integrative Environmental Health Sciences
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →louisville.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
James Franciosi, MD
University of Louisville
David Tollerud, MD
University of Louisville
Goetz Kloecker, MD
University of Louisville
Ryan Doster, MD
University of Louisville
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic